# In silico nephroprotective evaluation of microbial biotransformed metabolites from Aframomum melegueta

## TL;DR

This study explores how microbes transform natural compounds from Aframomum melegueta into new forms that may protect the kidneys by interacting with a key protein.

## Contribution

The paper introduces a novel use of microbial biotransformation to generate nephroprotective metabolites and evaluates their binding affinity to AMPK for the first time.

## Key findings

- Microbial transformation produced five new metabolites with potential kidney-protective properties.
- M1 showed the highest binding affinity to AMPK, indicating strong therapeutic potential.
- Biotransformed metabolites demonstrated better or comparable activity to their natural precursors.

## Abstract

Microbial biotransformation of three bioactive phenolic constituents from Aframomum melegueta K. schum, namely 6-gingerol, 6-paradol and 6-shogaol, was performed by Bacillus subtilis 168, Pseudomonas aeruginosa PO1A and Candida albicans ATCC10231. Structures of the isolated compounds were determined using LC/MS analyses. To assess and compare their potential nephroprotective effects, the parent compounds and their biotransformation metabolites were subjected to molecular docking studies targeting AMP-activated protein kinase (AMPK) for the first time. During microbial biotransformation, a series of reactions, primarily hydroxylation and reduction, were observed, resulting in the identification of five distinct metabolites. LC/MS analysis of the fermentation medium revealed that Bacillus subtilis 168 converted 6-gingerol into 6-gingerdiol (M1) and hydroxylated 6-gingerol (M2), while 6-shogaol was transformed into 6-paradol (M3) and hydroxylated 6-shogaol (M4). Additionally, 6-paradol underwent further reduction to form (M5). Docking results showed that all compounds demonstrated binding affinity to AMPK, indicating potential nephroprotective activity. Notably, M1 exhibited the highest binding affinity, suggesting its strong therapeutic promise as a nephroprotective agent of natural origin. M5 ranked second in binding affinity, followed by M4. These results highlight the effectiveness of microbial transformation in generating bioactive derivatives with potentially enhanced biological activity compared to their natural precursors.

The online version contains supplementary material available at 10.1186/s13568-025-01962-x.